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PART I.
Before reporting the technical aspects of the method
of treatment which we have recently practiced it may be
well to consider very briefly those aspects of the pathol-
ogy of leukemia which bear on the matter of the topical
treatment with agents such as the x-rays and also to
review the facts that have become known regarding the
probable effects of the x-rays on the tissues in this dis-
ease.
PATHOLOGY OF LEUKEMIA.
The gross lesions observed in leukemia, whether of the
lymphatic or lienomedullary form, are much the same.
There is found an infiltration of a grayish white charac-
ter in the spleen, bone marrow or lymph nodes, or in all
of these structures, and not infrequently a similar
change in the liver, kidneys and other glandular organs.
In the so-called lymphatic form, these changes are espe-
cially pronounced in the lymphatic nodes, and macro-
scopically may be confined to these structures. In the
lienomedullary form the changes are more evident in the
spleen and bone marrow.
Discussions regarding the essential pathology of leu-
kemia have grouped themselves about several main prop-
ositions: (a) The organ or structure first involved; (b)
the nature of the process; (c) the question whether the
secondary infiltrations in other organs represent simple
infiltration processes, or active proliferative growth
from deposited cells derived from the original foci.(a) The first of these questions has finally been set-
tled, in the opinion of the great majority of patholo-
gists, in favor of the bone marrow. Until late years
cases of lymphatic leukemia were supposed to have no
relation to disease of this structure, but numerous re-
cent studies have proved that even in lymphatic leuke-
mia, whether of the acute or chronic variety, definite
changes are found in the bone marrow, and in some of
these cases the medullary changes have been present
when no alteration was yet discoverable in the lymph
nodes, either macroscopiçally or microscopically. So far
as lienomedullary or mixed forms of leukemia are con-
cerned, pathologists have, for a long time, more unani-
mously regarded the bone marrow as the primary seat
of disease.
(b) Regarding the nature of the process it is impos-
Read before the American Roentgen Ray Society, Cincinnati,
Oct. 3, 1907.
sible to dogmatize. Our own opinion, expressed in other
places, has, for a long time, inclined us to believe that
the disease is closely related to neoplastic processes.
There is an undoubted close connection between certain
sarcomata and leukemia. The histologie features, the
progress of the disease, the métastases, and the clinical
analogies suggested by cases of undoubted sarcoma tend
to confirm this opinion.(c) So far as the secondary changes in the spleen,
liver and other organs are concerned, opinions have dif-
fered widely. Virchow, in his early descriptions, indi-
cated the resemblance of these lesions to métastases of
tumors, but subsequently a different interpretation
gained ground, attributing the secondary lesions to a
metaplasia of the normal tissues of the organs involved,
to proliferation of "rests" of myeloid elements or to
hyperplasia of the ordinary structural components of
the organs involved. It is important to recognize that
the histologie study of the secondary lesions in mixed
leukemia shows a large proportion of myeloid elements(myelocytes, eosinophile myelocytes, erythroblasts). The
picture is that of a myeloid transformation of the nor-
mal structure.
Three interpretations of this are possible: (1) That
there has been a direct myeloid metaplasia; (2) that
there has been a rapid proliferation of myeloid "rests,"
and (3) that there has been metastatic deposit of mye-
loid elements, with subsequent proliferation in loco. We
can not enter into a complete discussion of this matter
here, but may state that practically all recent writers
incline to the belief that the third of these possibilities
is the most probable. In the case of lymphatic leukemia,
the evidence is somewhat less satisfactory, though in
this case, also, the trend of recent opinion is in the
direction of proliferation of metastatic cells in the or-
gans in which they have been deposited.
To a certain extent the cellular elements of the lesions
in the liver, spleen, lymph nodes, etc., are purely filtra-
tion deposits which have resulted from the excessive
number of leucocytes in the circulating blood. The
rapid fluctuation in the size of the spleen and lymph
nodes observed in some cases is evidence in favor of the
presence of new deposits of cells that have no fixed rela-
tion to the structure of the organs involved.
TREATMENT.
It is unnecessary to enter on a discussion of the medi-
cal treatment of. this disease. So far as drugs are con-
cerned, it has been clearly shown that, with the excep-
tion of arsenic, which occasionally exercises an inhibi-
tive or even temporarily curative effect, medicaments
are practically valueless.
The fact that certain cases of leukemia have under-
gone spontaneous cure as a result of intercurrent infec-
tions, or more often have been profoundly altered in
their course by such an event, has led to the use of vac-
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cination (vaccinia) and more recently to injections of
various sera in the hope that a similar effect might be
produced. These experiments have thus far proved
ineffectual.
The most striking results from treatment have been
those obtained from exposure of the patient to the
x-rays. Experiments have heretofore directed the rays
to the organs obviously enlarged, such as the spleen andlymph nodes. A consideration of the pathology of the
disease and of the known facts regarding the effects of
x-rays has, however, convinced us that this method of
application can accomplish a desired result only in a
round-about fash ion.
The experiments of Heineke, Linser and Helber, and
Capps and Smith have shown that the x-rays have a
decidedly destructive effect on leucocytes, especially the
mononuclear cells and myelocytes, and Capps and Smith
particularly found that there are thus produced leuco-
lytic substances which have the power of destroying
other leucocytes, either in the exposed individual or in
others into whose circulation the serum from the ex-
posed case has been injected.
The effect, then, of treating with arrays the spleen
or lymph nodes of leukemic patients may be stated as
follows : First, there is destruction of certain cells(mainly mononuclear leucocytes and myelocytes) in the
parts treated; second, as a result of such destruction,
leucolytic substances are produced and liberated; third,
these substances, reaching the bone marrow and other
affected parts, destroy a certain number of cells in these
situations. It is apparent, then, if the asserted facts
are true, that the source and origin of the disease (the
bone marrow) is reached in a round-about way. If this
could be treated more directly, the effect on the whole
course of the disease might be controlled more-readily.
Moreover, it might be expected that the violent reac-
tions (fever, collapse, etc.) sometimes caused by ex-
posure of large deposits of vulnerable cells (as in the
spleen and lymph nodes) could thus be avoided, while a
much more direct and beneficial influence on the con-
tinued existence and spread of the disease would be exer-
cised. Our experiences seem to justify the probable
truth of these assumptions. In the cases in which we
have substituted treatment of the bone marrow for that
of the spleen, we have found a decided diminution in
the reactions-that have been so commonly observed when
the older method of treatment was employed, and at the
same time the effect on the number of leucocytes in the
circulating blood and on the size of the spleen has been
altogether more continuous and progressive.
PART II.
From the standpoint of x-ray therapeutics, the un-
satisfactory ultimate results which have been uniformly
obtained up to the present time, and the lack of con-
formity of these results, as a whole, with the compara-
tively large percentage of primary symptomatic cures
or initial improvements which have been reported, cer-
tainly justify a fair trial of any radical departure from
the technic hitherto employed, provided such a change
is rational and is based on sound scientific principles.
In a paper read before the American Roentgen-Ray
Society in September, 1907, one of us presented a sta-
tistical report of the results, as a whole, which had been
obtained up to that time. The data were derived from a
review of the literature on the subject, and from replies
to personal letters requesting the final outcome in a
number of cases, the reports of which were incomplete
in one way or another.
The results of this investigation were discouraging, so
far as they concerned the ultimate success of the treat-
ment, but were not surprising. From the two sources
mentioned, reports of 123 cases of leukemia treated by
the »-rays were collected. Of this number, 83, or about
67.5 per cent., were of the splenomyelogenous variety;
30, or about 24.5 per cent., were lymphatic cases, and 10,
or about 8 per cent., were unclassified. Complete andfinal reports were obtainable in 69 of these cases, or
about 56 per cent., and the ultimate results of the treat-
ment of this number, corrections being made for data
received later, are represented in Table I :
TABLE I.
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Permanent cures
.
.
:. 3 3 0 6 8.7
Died, or in critical condition at
last report 33 20 4 59 85.5Still under treatment for relapses
following symptomatic cures.... 4 0 0 4 5.8
Totals
. 42 23 4 GO 100.0
It is plainly to be seen, therefore, that the x-ray as a
therapeutic agent does not offer much hope of ultimate
success as hitherto employed in the treatment of leuke-
mia. On the other hand, the results indicated by Table
II show that it has a very decided and powerful thera-
peutic action when applied to leukemic patients:
TABLE II.
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Primary symptomatic cures, not
permanent. 20' 5 0 25 36.23
Initial improvement noted, not
permanent 14 6 1 21 30.43
Total cases in which more or less
benefit was noted, primarily. .34 11 1 46 66.66
Cases in which there was little
or no favorable reaction. 5 9 3 17 24.64
Permanent cures. 3 3 0 6 8.70
Totals
. 42 23 4 69 100.00
The fact that a therapeutic agent is capable of so pro-
found an influence on a disease as to produce such pri-
mary results as are indicated by these figures is sufficient
reason for us to make every effort to satisfactorily ex-
plain our inability, when employing it in the treatment
of the disease, to effect permanent cures in more than 8.7
per cent, of the cases treated.
This lack of conformity of ultimate results with favor-
able primary effects means one of two things: (1)
Either x-ray treatment is not capable of accomplishing
any better results than those so far obtained, or (2),
taking for granted that it is capable of curing the dis-
ease by a removal of the cause, directly or indirectly, ifproperly employed, then there must be something radi-
cally wrong with our present method of administeringthe treatment.
'
The latter hypothesis gives a more
promising outlook for the patient and at the same time
is rational and conservative. It is our purpose to sug-
gest a form of x-ray treatment for leukemia which not
only seems more appropriate and more scientific theo-
retically, than the method hitherto employed, but its
merits have been demonstrated practically by superior
clinical results.
Personal experience and the information derived from
discussions and an incomplete perusal of recorded re-
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ports had almost led to the expectation that a review
of the literature would reveal the fact that not a single
case of leukemia had ever been permanently cured di-
rectly and solely by x-ray treatment. Therefore, even
the small percentage of cures found on record was some-
what surprising. Small though this figure is, however,
no other form of treatment can accomplish more nor
perhaps as much, and it is sufficient to have made the
employment of the x-ray worth while. But the large
percentage of ultimate failures following, with compara-
tive frequency, the most promising primary results, has
been discouraging to most radiographers, and in some
instances almost brought the treatment into disrepute.
An important fact is revealed by a careful study of the
records. Undoubtedly the x-ray has been used carelessly
and injudiciously in many instances, although such a
charge could be definitely proved in connection with but
few of them.
The discouragement shared with others who have had
experience with this treatment has been an incentive to
investigate the cause of our failures rather than to give
up hope of better success. Numerous' modifications in
minor details of the technic were tried experimentally,
but failed to yield any better results.
Certain facts which have been satisfactorily proved,
experimentally and clinically, may be mentioned as addi-
tional evidence in support of the modification of the
treatment herein suggested:
1. Heineke and Warthin have proved conclusively
that the effect on the hone marrow of animals subjected
to prolonged x-ray exposure is essentially the same as
that on the lymphoid tissue.
2. If we assume that the bone marrow is most likely
the actual seat of the disease, and that the enlarged
spleen is but a secondary manifestation, then the treat-
ment by applications of the x-ray to the latter is directed
against a result, and not the cause or seat of the disease.
The comparative ease with which this large mass of
lymphoid tissue is destroyed, when exposed directly, has
been explained in the results of the experiments of
Heineke and Warthin on animals and the metabolism
investigations of Edsall and others in connection with
leukemic patients. In animals the rapid destruction of
the lymphatic tissues and bone marrow is ascribed to an
autolytic process, instituted or stimulated by the pro-
longed direct x-ray exposures. It can not be proved
that the same phenomena take place in man, because we
can not subject our patients relatively as long. More-
over, we are not justified in drawing definite conclusions
nor in making comparisons from the results of x-ray
exposures on healthy animals, on the one hand, and
leukemic patients, on the other. But, at any rate, there
is some similarity in the results in the two instances.
Our clinical observations have shown that a single
application directly over the enlarged spleen of a leu-
kemic patient is usually followed, in a few hours, by a
very decided drop in the leucocyte count, and if the
exposure has been long enough, by evidences of a toxe-
mia. As a single exposure does not perceptibly reduce
the size of the spleen, we must assume, «from our present
knowledge, that this rapid destruction of leucocytes in
the blood is also due to an autolytic process. The fact
that the count will invariably rise soon afterward to a
point as high as or even higher than those before shows
that the spleen is still active.
There is also reasonable ground for the belief that the
products of disintegration of the leucocytes become ac-
tive factors in the destructive process and may, perhaps,
exert some inhibitory influence on the activity of the
pathologic parent cells. The destructive action of some
of these products on renal cells has been demonstrated
postmortem in a few cases in which' death has resulted
directly or indirectly from a toxemia during x-ray treat-
ment.
During the earlier exposures it is the cells circulating
in the blood which are actually destroyed. Whether or
not the destructive agents are active in the blood or in
the lymph structures, especially the spleen, or in both,
it is almost certain that they are present in the blood.
Bepeated experiments by Smith and Capps have shown
that the serum of leukemic patients under x-ray treat-
ment, when injected into other leukemic patients, caused
a rapid and decided drop in the leucocyte count of the
latter, followed soon afterward by a rapid rise, to a
point as high np or higher than before. When such serum
was injected into healthy animals, the effect was simi-
lar, and the more favorably the patient had responded
to the treatment the more marked was the reaction.
On the other hand, injections of normal serum or that
taken from leukemic patients before x-ray exposures
were begun were followed by a leucocytosis. These same
observers have noted that the sera of lymphatic and
splenomednllary cases under treatment seemed to have
a selective action on the lymphocytes and myelocytes,
respectively, in the blood of patients who had not been
treated.
After several applications have been made directly to
the spleen, a gradual and progressive reduction in size
usually follows. This may be clue to the destructive
effect of the cumulative action of the rays, such as lias
been observed in animals, but such an explanation is not
altogether satisfactory, in view of certain observations
that have been made in connection with the treatment
of some of our cases. These points will be discussedlater in the conclusions drawn from our study of clinical
results.
3. A rapid destruction of lymphoid tissue, such as is
apt to follow direct splenic exposures, is not always wise
or safe, as a toxemia is easily induced thereby. Thatdeath has frequently resulted under such circumstances
can not be denied. At any rate, such procedures are far
from beneficial to the patient and are likely to lessen the
chances of ultimate cure, for any conditions which tend
to lower the general vitality may thereby give the fac-
tors causing the disease an opportunity to operate withincreased vigor.
CLINICAL OBSERVATIONS.
Five patients have been treated so far by the method
herein suggested, and the clinical results have, on the
whole, fully justified the change. It is too early to
make deductions as to the ultimate success of the method
or the special technic we have adopted, but there is
every reason to believe that the final results will be su-
perior to those heretofore realized, and especially in
connection with the splenomedullary type of the dis-
ease. One result of our experience and observations has
been a decided change of view in regard to many pointsin connection with the treatment. For example, com-
paratively little attention is now paid to the total leu-
cocyte count as an index to the effect of the treatment
on the disease, while far more is given to the differ-
ential counts and to the general qualities of the blood.
Our rules are not influenced by a tendency of the
leucocytosis to remain high for a_ comparatively longperiod after the treatment has been started, and our
efforts are now directed, the least of all, to a reduction
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of the count, and, in fact, a rapid and decided drop is
considered most undesirable.
THE TECHNIC.
The details of the teclmie as now carried out are based
largely on our clinical experience and observations. The
following points are to be considered in its application :
1. The length of each exposure.
2. The frequency of exposure.
3. Avoidance of toxic reactions.
4. Systematic applications.
5. Avoidance of early splenic exposures.
6. The duration of the entire treatment.
1. The duration of our standard exposure is based
primarily on the observations of Heineke, that' the short-
est time in which any perceptible degenerative changes
in the lymphoid tissues of a moderate sized dog or rabbit
could be induced was fifteen minutes, and that the reac-
tion of bone-marrow in a given time was much less
marked in all instances. The reaction of the same tis-
sues in man is, of course, much less prompt and less de-
cided. An attempt to bring about any perceptible de-
generative changes in these tissues by a single applica-
tion to a leukemic patient would be dangerous, and
probably fatal, but our experience has shown that an ex-
posure of fifteen minutes to the bone-marrow, under
standard conditions, is not attended with any risk, as a
rule, and is sufficient to produce some reaction. On the
other hand, even this is sometimes too long an exposure,
especially when applying the rays near the splenic re-
gion, or sometimes over the knees even, as will be shown
later.
Heineke and Warthin observed that a single short ex-
posure produced no perceptible reaction in the bone-
marrow of animals, while repeated short exposures did
so ultimately. They also found that regeneration was
possible if the applications were discontinued. There-
•
fore, in view of these facts, it would seem necessary to
expose a given area repeatedly before leaving it to take
up another part of the body. In the beginning it was
our custom to expose each separate area three times in
succession, but later observations have led to a slight
modification of this rule.
Taking fifteen minutes as the standard length of ex-
posure, the actual duration of each application depends
on the particular circumstances attending each individ-
ual case. The duration of exposure is a matter which
requires careful consideration for the reason that it is
an indefinite factor, subject to more or less variation in
the determination of a standard dosage. Under ordi-
nary circumstances the slight variations in the thera-
peutic x-ray dose, arising from the differences in ap-
paratus, are unimportant, but in the treatment of leu-
kemia unusual accuracy is desirable. Time can not be
an absolutely uniform unit, because, being under con-
trol as a measurable quantity, it must be the factor to
be adjusted in order to allow for the uncontrollable
variations in the other factors which determine the
therapeutic dose. As there is no accurate method for
determining directly the volume of the rays generated
in a tube, this unit must be measured approximately,
and is most accurately estimated from the relations of
the vacuum of the tube and the milliamperage of the
current delivered to it.
As the quality of the rays also depends more or less
on the vacuum of the tube, and as the quality or degree
of penetration must be as nearly uniform as is possible
in the treatment of leukemia, it follows that the vacuum
will not be a very variable factor, because it must, of
necessity, be a uniform unit, and it is more or less con-
trollable as such. A "four-inch" vacuum is about right
for the purpose, and there should be a tendency for it
to rise and not to fall. Such a vacuum must be main-
tained by automatic regulation. If the tube and its
vacuum can be made a uniform unit it is very easy to
make the measurement of the current the same for all
cases.
'
The only important variable factor now remaining is
the variety of interrupter used. All other factors re-
maining practically the same, there is undoubtedly some
difference in the resulting doses when a mechanical
spring interrupter is used and when a Wehnelt instru-
ment is employed. The adjustment of this difference is
largely a matter of experiment and experience. Marked
variations in distance, of course, necessitate correspond-
ing changes in the time unit.
2. The frequency of the applications is a matter re-
quiring some consideration, although its importance was
not evident to us at first. In our experience daily ex-
posures, when it is possible to give them that often
and they are not followed by undesirable effects, are
advisable, for the reason that it requires a considerable
period of time to cover the entire body, and it is not
best to allow too long an interval to elapse between the
time one area has received its series until its turn comes
again for the next. Regeneration might take place werethis interval too long, or at least the cells might have
a chance to recover from the effects of the previous ap-
plications. This form of treatment requires a much
longer time than the older method, but by making the
applications daily its duration may be shortened several
weeks or even months. At any rate, our best results
have been noted in those cases which have received daily
exposures.
3. There is reason to believe that any exposure which
produces the slightest toxic manifestations may be harm-
ful rather than beneficial. Toxemia is most likely to
follow direct applications to the spleen or enlarged
lymph glands, but it sometimes follows exposures to the
bones alone, especially when they are made over the
knees. Evidences of toxemia early in the course of the
treatment have been taken as a warning, first, to keep
away from the spleen for some time, and, second, to
shorten the applications. If toxemia still follows, the
prognosis is unfavorable.
It is not likely that any benefit is to be derived from
the treatment of acute cases, whether the attack is pri-
mary or a relapse. The same may be said of those in
which there are evidences of a marked toxemia. In
fact, Roentgen-ray applications may shorten life in such
cases.
4. To be of any real value this treatment must be
systematic. The exposures to the different areas of, the
body must be made with some definite regularity and
system. Heretofore when the bones were exposed, in
connection with the splenic applications, either it was
carried out in a more or less general exposure of the
patient's entire body, or only a very few areas receiveddirect applications, which were usually of comparatively
short duration. In the former instance the element of
distance was disregarded and uniformity was out of the
question. Even if such widespread applications were
of sufficient duration to induce any reaction in the
bone-marrow the exposure of such a large extent of
surface at one time would have incurred risk in many
instances.
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AREAS FOR EXPOSURE.
In any method of applying the treatment to the bone-
marrow the body should first be divided into definite
regions, and each of these should be exposed with regu-
larity. The manner in which we have mapped out the
areas for exposure is as follows :(1) The feet, ankles and lower halves of the legs.(2) From the middle of the legs to the middle of the
thighs.(3) The right half of the abdomen and pelvis and the
upper half of the right thigh.(4) The corresponding area on the left side, carefully
avoiding the spleen in the earlier applications, but in-
cluding its lower half later on.(5) The right half of the thorax and the right shoul-der, including as much of the upper extremity as pos-
sible.(6) The corresponding area of the left side, again
avoiding the spleen early, but including its upper halflater on.
(7) Later in the treatment the entire thorax and both
shoulders are often included in one application, making
the proper correction in time for the increase in dis-
tance. In stout subjects it may be advisable to treat thispart of the body posteriorly as well.(8) When it is safe to expose the entire spleen it is
advisable to approach it from the back and thus include
the lumbar spine and the posterior aspect of the pelvis.Each of these regions is treated in rotation and re-
ceives three successive exposures. For reasons to be
mentioned later, a fourth is sometimes given. By divid-
ing the body up in this way, and making the relations
of distances and exposures uniform, it becomes a simple
matter to give each portion of the skeleton its proper
share of treatment. We have assumed that it is safer
to expose every portion of the skeleton, except the cra-
nium. If it is found necessary to expose the head the
patient must accept the risk of a possible loss of the hair.
5. In direct contrast to the older method of directly
exposing the spleen from the start, our experience has
demonstrated that this is an unwise procedure. This
does not mean that the spleen should never be exposed,
for to avoid it at all times would be almost impossible,
and, besides, more or less exposure is no doubt neces-
sary, but should not be attempted while the organ is
still very large and the leucocytosis is still high. It is
best to wait until the count is materially reduced and
the patient's general condition has improved consider-
ably. This mass of lymphatic tissue is far too suscep-
tible to x-ray influence, and the patient is not in a
condition at first to stand the strain imposed by its ex-
posure. ,
In all our cases except one the spleen has diminished
in size steadily, and with comparative rapidity without
direct exposure, while the applications were confined
strictly to the bones. Direct exposure to the spleen,
however, caused a more rapid decrease in size. It has
been clearly demonstrated, in our lymphatic case that
early splenic exposures are harmful. This patient had
been previously under the care of another physician, who
gave him three or four exposures directly over the spleen,
and he at once became much worse, while following the
bone exposures alone, after he came under our care, the
leucocyte count dropped steadily, his general condition
f-om the start showed a corresponding improvement,
and the spleen .steadily diminished in size. During this
time every precaution was taken not to expose the en-
larged lymph glands. Any application near the spleen,
when it would be more or less in the path of stray rays,
was immediately followed by toxic symptoms. Similar
manifestations were associated with the earlier exposures
to the lymph glands, unless the applications were made
much shorter than usual.1
The appropriate time for beginning splenic exposures
depends on the circumstances attending the case. It
has been our rule to go over the entire body at least
twice with the bone exposures, keeping well away from
the spleen, before considering its exposure. In the
average case, with moderate leucocytosis, moderate
splenic enlargement, and little or no evidence of tox-
emia, it may be safe to try the experiment of including
the lower half of the spleen with the left hip during the
third series, provided the patient's general condition has
improved to a considerable extent. We have found it
best to try an exposure of only eight minutes, or not
more than ten at first, and then if there is no unfavor-
able reaction a second application may be given, followed
by the third if all goes well. We never expose any part
of the spleen for the full fifteen minutes until much
later.
The reason for these precautions has been demon-
strated practically in connection with Dr. Stengel's pa-
tient, who has the first to be treated by this method.
Being himself a physician, he was in a position to render
valuable assistance in the experimental stage of our
work. Early in the course of his treatment he found
that thirteen minutes' exposure over half or more of the
spleen would be followed in from two to six hours by
mild toxic symptoms, accompanied by the appearance
of a trace of albumin in the urine; fourteen minutes
made him decidedly toxic, and fifteen minutes was not
then tried. Later on we found that fourteen minutes
was the border line, and at the present time he can
stand a fifteen minutes' exposure without the slightest
evidence of toxic manifestations. We have now reached
the point of seventeen minutes, although the first time
it was tried there was a suspicion of toxemia, but no
albumin appeared in the urine.
This patient has observed that the series of splenic
exposures invariably resulted in considerable local dis-
turbance, which he attributed to a shrinking of the
spleen, and sometimes there was an additional sensation
which he thought might be due to the breaking up of a
slight adhesion. These phenomena, which were noted
only after the institution of the present method of treat-
ment, were always accompanied by a decided increase in
the leucocytosis, but after the third exposure of the
series the count usually dropped to a point as low as or
even lower than it was before. Previously the patient
had received seventeen direct applications to the spleen.
These exposures were accompanied by a very decided
progressive drop in the leucocytosis, without any appre-
ciable diminution in the size of the spleen, which would
tend to prove that these early, direct, splenic applica-
tions destroyed only those lymphocytes circulating in the
blood. With the institution of the bone treatment the
count soon rose again, but the general condition began
to improve at once and continued to do so. With this
early reduction of the leucocyte count there was no cor-
responding reduction in the number of myelocytes, their
percentage rising proportionately.
It should be borne in mind that the periods of time
1. This patient later became dissatisfied with our treatment, and
went to another hospital, where his spleen and enlarged glands
were again exposed in the old way. As a result, when he came back
to us he was so much worse that x-ray treatment was contraindi-
cated.
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mentioned above are relative factors in the dosage and
are not intended to be taken as uni form standards.
While the spleen still remains very large, it does not
seem advisable to expose the entire organ at any one
time, but this may be attempted with safety when the
enlargement has diminished to a moderate size, provided
other conditions do not contraindícate such a procedure.
This would be at a comparatively late stage in the treat-
ment, after the leucocyte count has become steady and
is not subject to wide variations, and there has been a
decided improvement in the patient's general condition.
There is no reason to fear any damage to the kidneys
from their direct exposure to the rays while making
applications to the spleen through the back. It has been
satisfactorily proved that all renal complications which
have arisen during the treatment of leukemic patients
have resulted from oxer-taxation in the elimination of
waste tissue producís and have not been due to direct
x-ray exposure.
6. The point about which we acknowledge the great-
est indecision is the appropriate time to stop treatment
altogether. If we stop too soon, before the elimination
of the cause is complete, we run the risk of a possible
regeneration of leukemic tissue, with a resulting re-
lapse. Experience has demonstrated that the prognosis
in the treatment of relapses is far less favorable than
in the case of a primary attack. And at any rate, we
would have the same ground to go over again. On the
other hand, it is not desirable to prolong the treatment
unnecessarily, at the expense of both time and money to
the patient, and with the possibility that overexposure
may be productive of harmful results. Our experience
has not yet decided this point.
We have noted that toward the apparent end of the
treatment the leucocyte count falls very slowly, but itbecomes quite steady. One of the evils of splenic treat-
ment was the too early reduction of the leucocytosis,
which, when it reached a numerically normal figure, was
taken as an indication of a symptomatic cure long be-
fore it was possible for the disease to have been eradi-
cated. A continuance of the treatment resulted in a
subnormal count, which might be harmful. No such
confusion exists in connection with the bone-marrow
treatment. We are paying less and less attention to the
leucocytosis, for it is by no means an accurate index of
the patient's condition. For example, one of our pa-
tients has had a count hovering steadily between 20,000
and 26,000 for several weeks, and we consider him very
nearly cured. In another case the count has been under
20,000 for nearly as long, and yet the patient is very
far from being well. In the splenomyelogenous cases
it is most important that the myelocytes be driven out
of the blood and that they remain out.
It is mentioned elsewhere that every time a new area
is exposed for its series a rise in the leucocyte count
follows the first or the second application. We have no-
ticed that this tendency diminishes and the count be-
comes more steady as the patient's general condition
approaches the normal. Earlier in the treatment the
count frequently does not come down after the third ap-
plication to where it was before the first treatment of
that part. Under such circumstances we repeat the
exposures until there is a satisfactory drop. As a rule,
only one additional application is required.
A reduction of the leucocytosis to a moderately low
count, with very little fluctuation, a reduction of the
spleen to nearly a normal size, and a return of the gen-
eral condition to normal may be taken as indications to
let up in the treatment, but applications would best notbe stopped altogether for some time. While any splenic
enlargement persists there is apt to be a slight leucocy-
tosis. It would hardly seem wise to stop the treatment
while the spleen still shows a tendency to diminish in
size, but it must be remembered that an enormously en-larged spleen can rarely be reduced to a normal size by
treatment.
Not only is it a serious mistake to stop treatment too
soon, but it is equally as injudicious to allow long inter-
vals of rest during the course of the treatment. There is
reason to believe that the latter was the cause of a fatal
result in one of our cases. The patient was permitted
to take a rest of ten days, but no longer, at the seashore.She remained there for nearly a month, had an acute
relapse, and soon died. Under certain circumstances
some benefit may be derived from a short restful vaca-
tion of a week or ten days, but no longer than that.
Judging from our experience, it would not be
safe in the average case to stop the treatment short of
100 applications, and in some instances as many as 200
might be necessary. Daily exposures may diminish the
total number of applications necessary.
GENERAL CONCLUSIONS.
The reason for presenting such a detailed discussion
on this subject is the desire to give to others the fullbenefit of our experience in the application of what
promises to be a more successful method of treating
leukemia. As clinical reports are lengthy and uninter-
esting, and as there are already on record a sufficient
number of them referring'to the x-ray treatment of this
disease to give a fairly correct idea of the results in gen-
eral, detailed reports of our limited number of cases will
be omitted. The following conclusions are a résumé of
what we have accomplished so far in the treatment of
five eases by this method, together with the more impor-
tant observations that have been made :
1. The primary results of this method are equally as
good as those of the one hitherto employed.
2. The treatment herein suggested is more rational
because it is directed against the prmiary focus of thedisease, so far as it is known, and not against a second-
ary manifestation.
3. Toxemia resulting from the treatment may be
avoided, and the patient's general condition is, on the
whole, better from the start.
4. Under exposures to the bone-marrow the enlarged
spleen is diminished in size just as it is under direct
splenic applications, only the process is somewhat slower.
5. Although this treatment requires a much longer
period of time, the misleading tendency of a compara-
tively quick symptomatic cure, such as follows direct
splenic exposures, is avoided. Applications confined
mainly to the spleen reduce the size of that organ, de-
stroy the leucocytes in the circulation, including the
myelocytes, and possibly have some inhibitory influence,
secondarily, on the cause, and hold the disease in check,
leading to an impression that the case is cured, whereas
statistics show that this is seldom the case. Applica-
tions to the bone-marrow also reduce the size of the
spleen and destroy the leucocytes circulating in the
blood, but, in addition, they are more likely to reach and
remove the cause of the disease.
6. The spleen should be exposed at some time, but
never until it is considerably reduced in size and the pa-
tient's general condition is markedly improved, and even
then it should be done with caution.
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7. The comparatively slow reduction in the size of the
spleen, while it is not being directly treated, may be afactor in keeping the leucocyte count high. This is in
a measure advantageous, as it guards against stopping
the treatment too soon. The count will not become nor-
mal while the spleen is still enlarged and is still dimin-
ishing in size.
8. That actual destruction of the splenic tissue results
from the cumulative effect of direct x-ray exposures is,in a measure, disproved by the following observations :(a) The spleen is diminished in size by applications
to the bones alone.
(b) In all of our cases which have reacted favorably
to the treatment, it has been noted that after the spleen
has been included in the applications, the first or second
exposure in each series is usually followed by a decided
rise in the count, associated very often with evidences of
more or less diminution in the size of the tumor. A
third or fourth exposure usually brings the count down
again by a destruction of the lymphoóytes in the circu-
lation. These facts would seem to indicate some direct
connection between the decrease in the size of the spleen
and the increase in leucocytosis and lymphocyte percent-
age.(c) In the first patient seventeen, almost daily, splenic
applications of short duration, made before starting the
bone-marrow treatment, reduced the leucocyte count
from 386,000 to 133,000, with a relative increase in
myelocytes from 16% per cent, to 25^ per cent., but
there was comparatively little diminution in the size of
the spleen. •(d) In the two unfavorable cases with acute relapses,
repeated direct applications had no effect whatever on
the spleen, which continued to grow larger. At the same
time the leucocyte count rose rapidly, although the first
one or two direct splenic exposures were followed by a
decided drop, which lasted for a day or two only. It
may be well to explain that the reason for these direct
splenic exposures was the fact that bone-marrow appli-
cations had no effect whatever in cheeking the extremely
rapid enlargements of these spleens, and it was hoped
that comparatively short and safe direct exposures might
have some such influence. So rapid was the enlarge-
ment in one of these two cases that death occurred very
suddenly, following phenomena which may have beendue to a rupture of the spleen.
9. A peculiarity of this treatment is the fact that the
patient may feel perfectly well, but still have a moder-
ately high leucocytosis and a comparatively large spleen.
In our first case, after 112 treatments during a period
of ten months, the count still averages from 75,000 to
100,000, with 3 to 4 per cent, of myelocytes, and the
spleen is still moderately large, but the patient feels as
well as he ever did in his life, and is able to attend to
all of his work. He has been in this condition for
the past four months. His leucocytosis decreases very
slowly, but a slight drop is noted each time a new area
is exposed in its turn, as compared to the count at the
time of the previous series to the same part. The only
explanation for this long continued high leucocytosis
is that in its slow but steady decrease in size the spleen,
which receives but comparatively few direct exposures,
pours out large numbers of lymphocytes into the circu-
lation, where they are destroyed slowly. The presence
of 3 to 4 per cent, of myelocytes shows that this patient
is still far from well.
10. Daily exposures, when not contraindicated, may
frequently yield quicker and better results. The slow
progress made by the case just mentioned may be ac-
counted for by the fact that he received but three treat-
ments per week, and for a while only two. Our most
favorable case was treated daily.
11. All cases will not respond to even this method of
treatment. Jn acute primary attacks and relapses x-ray
treatment is perhaps, as a rule, contraindicated.
12. Lymphatic cases also respond well to this method
of treatment. It is advisable to observe the same pre-
cautions in regard to applications to the glands as those
mentioned in connection with the spleen.
13. Cessation of treatment for long intervals is to be
guarded against, especially in the early stages. Even
short interruptions are not advisable until the disease
is well under control.
14. The proper time to stop treatment is still a some-
what uncertain question. The frequency of the appli-
cations should not be lessened until the general condi-
tion is normal and the size of the spleen and the leuco-
cyte count nearly so. It would seem wiser to stop grad-
ually rather than abruptly.
15. The leucocyte count, per se, becomes a matter of
minor importance, but the differential count is always
one of the important indices to the effect of the treat-
ment. The failure of the count to drop, after the third
application in the series to any particular area, to a
point as low as or lower than before the first, has been
taken of late as an indication to give more than the
three customary exposures to that part. As conditions
begin to indicate the approach of a cure this tendency
of the leucocytosis to increase becomes less marked.
16. The distribution of the applications over almost
the entire body renders the risk of a severe dermatitis,
with ordinary care, very slight.
17. The bone pains, noted especially in splenomedul-
lary cases, are relieved early by this method of treatment.
COMPARATIVE POTENCY OF HYOSCIN AND
SCOPOLAMIN HYDROBROMID IN
REFRACTION WORK.
WENDELL REBER, M.D.
PHILADELPHIA.
Some years age in some notes1 on the mydriatic alka-
loids I made mention of a youth of 16 with emmetropic
eyes on whom I had tested the effects of hyoscin hydro-bromid and scopolamin hydrobromid. One drop of a
1/10 per cent, solution of the hyoscin salt was used in
the right eye and one drop of a 1/10 per cent, solution
of the scopolamin salt was used in the left eye. The
effect of the two drugs on the pupil is shown in Figure
1 and on the ciliary muscle in Figure 2. From these
results I leaned to the conclusion that the two drugs
were practically identical in action and, therefore, inter-
changeable, and I so put myself on record at that time.
For some time afterward I ordered 1/10 per cent, of so-
lutions of scopolamin or hyoscin hydrobromid indis-
criminately in my office refraction work, but it was not
long before the scopolamin cases began to show uncer-
tain cycloplegia, while the hyoscin cases seemed to be
much surer in result. Cases were, therefore,x sought out
that offered favorable conditions for further pharmaco-
dynamic comparative tests of the two drugs. Within
Read in the Section on Ophthalmology of the American Medi-
cal Association at the Fifty-eighth Annual Session, held at At-
lantic City[ill] June. 1907.
1. American Jour. Phar., 1899.
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